GREAT NEWS FOR ALL INDIAN EDUCATIONAL INSTITUTES TO BOOST THEIR INNOVATION

The Government of India notifies Patent Amendment Rules 2021 to reduce 80 per cent of patent filing fee for all educational institutes as recognized by an authority designated by the Central Government or the State Government or the Union territories. The fee is reduced by 80 percent as the Educational institutes which was under the Others category have now moved […]

Government Proposal to Shut Down IPAB

The Bill bearing the title “The Tribunals Reforms (Rationalisation and Conditions of Service) Bill, 2021”was introduced on Feb 11, 2021 in the Parliament by the Union Finance Minister. While seeking to dismantle the IPAB, the Bill proposes to transfer its powers to High Courts (for patent, trademarks, GI, Plant Varieties related issues) and to Commercial Courts (for copyright matters). The […]

New IPR Policy for Academic Institutions on the anvil

“The patent system added the fuel of interest to the fire of genius, in the discovery and production of new and useful things.”-Abraham Lincoln. No one can refute the words of Abraham Lincoln more so today, as we live in the knowledge era. Therefore, it has become imperative to enhance creativity, innovation and competitiveness by harnessing the IP of individuals, institutions, industry and the […]

Government of India initiative to boost Intellectual Property Rights

To nurture innovation and creativity in a knowledge economy, Indian Government has reduced the official fees for filing of patent application, requesting for normal or expedited examination and for renewing the granted patents to the tune of 60 to 68 percent especially for MSMEs who play a key role in the economic growth of India. The fee reduction has also […]

Patent infringement actions are maintainable only in respect of granted and live patents

On Aug. 20, 2019, High Court of Delhi Passed order that “Patent infringement actions are maintainable only in respect of granted and live patents.” Plaintiff: Novartis AG & ANR.      . Defendant: Natco Pharma Ltd. The suit concerns the Plaintiff’s patent number IN 276026 titled ‘Novel Pyrimidine Compounds and Compositions as Protein Kinase Inhibitors” relating Ceritinib drug for treating non-small cell […]

Is Nucleic Acid Primer a Patentable Subject Matter?

Biotechnology is any technique that uses living organisms (or parts of organisms) to make or modify products, to improve plants or animals or to develop micro-organisms for specific uses. The 21st century is the Age of Biotechnology and most important technological breakthroughs have been occurring during the last two decades. The biotechnology revolution has put a great strain on the legal […]